adorable baby smiling with joy

Peds Calc

Pediatric Reference

Augmentin Side EffectsComprehensive Pediatric Safety Guide

Augmentin (amoxicillin/clavulanate) is associated with higher gastrointestinal side effect rates compared to amoxicillin alone, primarily due to the clavulanic acid component. Diarrhea occurs in approximately 19.8% of patients receiving amoxicillin/clavulanate versus 8.1% with amoxicillin alone. Augmentin is currently the most common cause of drug-induced liver disease in the United States and Europe, though hepatotoxicity remains rare in pediatric populations. Most side effects are mild and self-limiting.

5 Categories
18 Clinical Sources
Evidence-Based
Back to Augmentin Overview

Essential Information

1

Gastrointestinal Effects

Diarrhea is the most common adverse reaction, occurring in 9-19.8% of pediatric patients depending on formulation and dosing. The clavulanic acid component increases GI intolerance compared to amoxicillin alone. Every 12-hour dosing is associated with less diarrhea than every 8-hour dosing. Management: Give with food to reduce stomach upset, maintain hydration, and consider probiotics (L. rhamnosus GG or S. boulardii at 5-40 billion CFU/day) for prevention. Monitoring: Watch for severe, persistent, or bloody diarrhea which may indicate C. difficile-associated colitis.

2

Hepatotoxicity

Augmentin is the leading cause of drug-induced liver injury globally, with hundreds of documented cases. Most cases present as cholestatic injury occurring 1-6 weeks after treatment initiation, though mixed hepatocellular patterns can occur. Pediatric cases are less common but documented. Management: Monitor liver function in high-risk patients or with prolonged therapy. Discontinue immediately if jaundice or liver injury signs develop. Monitoring: Watch for jaundice, dark urine, right upper quadrant pain, unusual fatigue, or pale stools.

3

Drug-Induced Enterocolitis Syndrome (DIES)

A rare but serious non-IgE mediated reaction characterized by protracted vomiting 1-4 hours after ingestion, occurring primarily in pediatric patients ≤18 years. Unlike typical allergic reactions, DIES lacks skin or respiratory symptoms. Can lead to severe dehydration and requires immediate medical attention. Management: Discontinue medication immediately, provide supportive care for dehydration, and avoid re-exposure. Monitoring: Report persistent vomiting, especially without other allergic symptoms, particularly in young children.

4

Tooth Discoloration and Oral Effects

Brown, yellow, or gray tooth staining can occur, primarily in pediatric patients during tooth development. Usually superficial and can be reduced with proper dental hygiene. Thrush (oral candidiasis) may also develop. Management: Maintain excellent oral hygiene, brush teeth after doses when possible, regular dental cleaning can eliminate most discoloration. Consider antifungal treatment for thrush. Monitoring: Watch for persistent tooth staining or white patches in mouth indicating fungal overgrowth.

5

Drug Interactions and Dosing Considerations

The 250mg tablet should not be used in children weighing <40kg due to excessive clavulanic acid content leading to increased diarrhea risk. Drug interactions include reduced effectiveness with antacids and potential interactions with anticoagulants. Management: Use appropriate pediatric formulations, separate antacids by 2+ hours, monitor INR if on warfarin. Monitoring: Ensure proper weight-based dosing and watch for signs of reduced effectiveness or increased bleeding if on anticoagulants.

Clinical Overview

Augmentin side effects are primarily gastrointestinal (diarrhea 9-19.8%), with hepatotoxicity being the most serious concern despite its rarity. Pediatric-specific issues include DIES (protracted vomiting), tooth discoloration, and the importance of weight-appropriate formulations. The clavulanic acid component is responsible for both increased efficacy and higher side effect rates compared to amoxicillin alone.

Side Effect Categories

5 Systems

Gastrointestinal

3 documented effects

Total Sources: 6

Diarrhea and Loose Stools

Incidence: 9% with immediate-release formulations; 19.8% for amoxicillin/clavulanate vs 8.1% for amoxicillin alone
Onset: Within 24-48 hours of first dose
Mild to Moderate (Grade 1-2)
2 sources
Duration

Usually resolves within days of treatment completion

Management

Give with food; maintain hydration; consider probiotics (L. rhamnosus GG or S. boulardii 5-40 billion CFU/day); every 12-hour dosing preferred over 8-hour

Monitoring Guidelines

Report severe, bloody, or persistent diarrhea >3 days; watch for signs of dehydration or C. difficile infection

2 clinical sources• PubMed • Clinical Guidelines • FDA

Nausea and Vomiting

Incidence: Nausea: 3%; Vomiting: 1% in clinical trials
Onset: Within hours of administration
Mild (Grade 1)
2 sources
Duration

Self-limited; usually resolves between doses

Management

Take with food to reduce stomach upset; ensure adequate fluid intake; consider dose timing adjustments

Monitoring Guidelines

Report persistent vomiting preventing oral intake or signs of dehydration

2 clinical sources• PubMed • Clinical Guidelines • FDA

Drug-Induced Enterocolitis Syndrome (DIES)

Incidence: Rare; primarily affects pediatric patients ≤18 years
Onset: 1-4 hours after drug ingestion
Severe (Grade 3)
2 sources
Duration

Can persist for hours; requires immediate intervention

Management

Discontinue medication immediately; supportive care for dehydration; avoid re-exposure; consider alternative antibiotics

Monitoring Guidelines

Watch for protracted vomiting without skin or respiratory symptoms; seek emergency care for severe dehydration

2 clinical sources• PubMed • Clinical Guidelines • FDA

Hepatic

1 documented effect

Total Sources: 2

Hepatotoxicity and Cholestatic Injury

Incidence: Rare but documented; most common cause of drug-induced liver disease in US/Europe
Onset: Typically 1-6 weeks after treatment initiation
Moderate to Severe (Grade 2-4)
2 sources
Duration

Variable; most recover but some develop chronic injury

Management

Monitor liver function in high-risk patients; discontinue immediately if liver injury suspected; supportive care

Monitoring Guidelines

Watch for jaundice, dark urine, right upper quadrant pain, unusual fatigue, pale stools

2 clinical sources• PubMed • Clinical Guidelines • FDA

Dermatologic

2 documented effects

Total Sources: 4

Skin Rashes and Urticaria

Incidence: 3% in clinical trials
Onset: Days 3-7 of therapy
Mild to Moderate (Grade 1-2)
2 sources
Duration

Usually resolves after discontinuation

Management

Discontinue if severe; antihistamines for mild reactions; topical steroids per provider guidance

Monitoring Guidelines

Watch for widespread rash, fever, blistering, or signs of severe allergic reaction

2 clinical sources• PubMed • Clinical Guidelines • FDA

Diaper Rash

Incidence: Common in young children taking Augmentin
Onset: Within days of starting treatment
Mild (Grade 1)
2 sources
Duration

Usually resolves after treatment completion

Management

Frequent diaper changes; barrier creams; antifungal treatment if candidal infection suspected

Monitoring Guidelines

Watch for severe, persistent, or spreading rash; report signs of secondary infection

2 clinical sources• PubMed • Clinical Guidelines • FDA

Oral/Dental

2 documented effects

Total Sources: 4

Tooth Discoloration

Incidence: Rare; primarily affects pediatric patients during tooth development
Onset: During treatment course
Mild (Grade 1, cosmetic)
2 sources
Duration

Usually reversible with dental cleaning

Management

Maintain excellent oral hygiene; brush teeth after medication when possible; professional dental cleaning

Monitoring Guidelines

Monitor for brown, yellow, or gray tooth staining; ensure proper dental hygiene

2 clinical sources• PubMed • Clinical Guidelines • FDA

Oral Thrush (Candidiasis)

Incidence: Common with broad-spectrum antibiotics
Onset: After several days of treatment
Mild to Moderate (Grade 1-2)
2 sources
Duration

May persist after antibiotic completion

Management

Antifungal medication (nystatin or fluconazole); maintain oral hygiene; probiotics may help prevent

Monitoring Guidelines

Watch for white patches in mouth, soreness, or difficulty swallowing

2 clinical sources• PubMed • Clinical Guidelines • FDA

Genitourinary

1 documented effect

Total Sources: 2

Vaginitis and Genital Candidiasis

Incidence: 1% in clinical trials
Onset: After several days of treatment
Mild to Moderate (Grade 1-2)
2 sources
Duration

May require specific antifungal treatment

Management

Antifungal medication; maintain hygiene; consider probiotics for prevention

Monitoring Guidelines

Report unusual discharge, itching, or discomfort

2 clinical sources• PubMed • Clinical Guidelines • FDA

Risk Factors

Age under 40kg (increased diarrhea risk with 250mg tablets due to excessive clavulanic acid)

Sources: 2 references

History of hepatic impairment or previous drug-induced liver injury

Sources: 2 references

Prolonged treatment courses (increased hepatotoxicity risk)

Sources: 2 references

Elderly patients (increased risk of jaundice and hepatotoxicity)

Sources: 2 references

Previous penicillin or cephalosporin allergy

Sources: 2 references

History of antibiotic-associated colitis or C. difficile infection

Sources: 2 references

Prevention & Safety Tips

Use probiotics (L. rhamnosus GG or S. boulardii at 5-40 billion CFU/day) to prevent diarrhea; give with food to reduce GI upset; use appropriate weight-based formulations; maintain excellent oral hygiene; complete full course even if symptoms improve; monitor liver function if risk factors present

When to Contact Your Pediatrician

Important

📞 Call your pediatrician immediately if you notice any of these symptoms:

Signs of liver injury (jaundice, dark urine, right upper quadrant pain, unusual fatigue)

Severe or bloody diarrhea with fever or cramping

Protracted vomiting 1-4 hours after medication (especially in children)

Signs of serious allergic reaction (widespread rash, difficulty breathing, swelling)

Severe dehydration from vomiting or diarrhea

Persistent tooth staining or oral thrush

Unusual bleeding or bruising (if on anticoagulants)

Comparison with Amoxicillin

EffectAugmentinAmoxicillin
Diarrhea19.8% (combination)8.1% (amoxicillin alone)
HepatotoxicityLeading cause of drug-induced liver injuryRare/minimal hepatotoxicity
GI toleranceHigher GI side effects due to clavulanic acidBetter GI tolerance

Important Drug Interactions

!

Antacids and Iron Supplements

May reduce absorption of amoxicillin/clavulanate; separate by 2+ hours

!

Anticoagulants (Warfarin)

May enhance anticoagulant effect; monitor INR closely

!

Oral Contraceptives

May reduce effectiveness; recommend backup contraception

!

Probenecid

Increases amoxicillin levels; may increase side effect risk

!

Live Bacterial Vaccines

May reduce vaccine effectiveness; complete antibiotic course before vaccination

Parent Communication Guide

Age-Appropriate Explanations

Infants (0-12 months)

Your baby's tummy might get upset from Augmentin - this happens to about 1 in 5 babies. Give the medicine with their feeding to help. Watch for loose stools or diaper rash. If baby has yellow skin or eyes, call us right away.

Toddlers (1-3 years)

Augmentin might give your toddler loose poops or tummy aches. This is normal and usually gets better. Give it with food to help their tummy. If they throw up a lot (especially 1-4 hours after taking it) or their skin turns yellow, call the doctor immediately.

Children (4-12 years)

Augmentin can cause diarrhea in about 2 out of 10 kids. Taking it with meals helps. Probiotics (special helpful bacteria) can prevent tummy troubles. Tell us right away if you see yellow skin/eyes, dark pee, or if your child throws up repeatedly after taking the medicine.

Adolescents (13+ years)

Augmentin causes diarrhea in up to 20% of patients due to the clavulanic acid component. Take with food and consider probiotics. Watch for signs of liver problems: yellowing of skin/eyes, dark urine, unusual fatigue, or right-sided stomach pain. Report persistent vomiting 1-4 hours after doses.

Common Parent Concerns

Q: How can I prevent diarrhea while my child takes Augmentin?

A: Give Augmentin with meals to reduce stomach upset. Ask about probiotics - studies show Lactobacillus rhamnosus GG or Saccharomyces boulardii (5-40 billion CFU/day) can reduce diarrhea risk by up to 64%. Use the every-12-hour dosing when possible, as it causes less diarrhea than every-8-hour dosing.

When to validate: Call immediately if diarrhea is severe, bloody, or lasts more than 3 days, or if your child shows signs of dehydration (dry mouth, no tears, decreased urination).

Q: What are the signs of liver problems I should watch for?

A: While rare in children, Augmentin can affect the liver. Watch for: yellowing of skin or whites of eyes (jaundice), dark brown urine, pale or clay-colored stools, unusual tiredness, loss of appetite, or pain in the upper right belly. These symptoms can appear during treatment or up to 6 weeks after stopping.

When to validate: Contact us immediately if you notice any yellowing of skin/eyes or dark urine. These require urgent evaluation as Augmentin is the most common antibiotic cause of liver problems.

Q: My child vomits after taking Augmentin - is this an allergy?

A: If vomiting occurs 1-4 hours after the dose without rash or breathing problems, this might be DIES (Drug-Induced Enterocolitis Syndrome), not an allergy. It's rare but serious and mainly affects children. Unlike allergies, there's no rash or swelling, just severe vomiting that can cause dehydration.

When to validate: Seek immediate medical attention for persistent vomiting 1-4 hours after doses, especially if your child becomes dehydrated. Do not give another dose - this reaction means your child cannot take Augmentin.

Q: Why does my child get worse diarrhea with Augmentin than regular amoxicillin?

A: The clavulanic acid in Augmentin makes it work against more bacteria, but it also causes more diarrhea - about 20% of children versus 8% with amoxicillin alone. Your doctor prescribed Augmentin because your child's infection needs the extra power. The diarrhea usually improves after treatment ends.

When to validate: Most diarrhea is mild and manageable. Call if stools are bloody, your child has severe cramping or fever, or if diarrhea persists more than 3 days after finishing the antibiotic.

Clinical Decision Support

Severity Assessment Framework

Evidence-based clinical assessment framework for Augmentin adverse effects with hepatotoxicity monitoring and ratio-based dosing decisions.

Mild (Grade 1)
Indicators: Diarrhea 3-4 stools/day above baseline, ALT/AST <3x upper limit of normal (ULN), No systemic symptoms, Maintaining hydration
Action: Continue Augmentin with probiotics (L. rhamnosus GG or S. boulardii 5-40 billion CFU/day), switch to q12h dosing if on q8h, ensure adequate clavulanate dose for infection
Moderate (Grade 2)
Indicators: Diarrhea 5-7 stools/day with cramping, ALT/AST 3-5x ULN or alkaline phosphatase 2-5x ULN, Mild jaundice or pruritus, DIES symptoms without severe dehydration
Action: Consider switching to amoxicillin alone if beta-lactamase coverage not essential, obtain liver panel, evaluate hydration status, document time relationship to doses
Severe (Grade 3-4)
Indicators: Bloody diarrhea or signs of C. difficile, ALT/AST >5x ULN or bilirubin >2x ULN, Cholestatic pattern with jaundice, DIES with severe dehydration, Symptoms 1-6 weeks post-treatment
Action: Discontinue immediately, obtain comprehensive metabolic panel and hepatic function tests, consider hospitalization for DIES, document for future avoidance, report to FDA MedWatch

Treatment Decision Guidelines

Immediate Discontinuation

  • Jaundice or laboratory evidence of hepatotoxicity (ALT/AST >3x ULN)
  • DIES (protracted vomiting 1-4 hours post-dose) - do not rechallenge
  • Severe or bloody diarrhea with systemic symptoms
  • Signs of cholestatic injury (pruritus, pale stools, dark urine)

Consider Alternatives

  • Persistent diarrhea >3 days affecting quality of life
  • Mild hepatic enzyme elevation (2-3x ULN) without symptoms
  • Inability to use appropriate ratio formulation for weight
  • Parent preference after risk-benefit discussion

Dose Modification

  • Switch from q8h to q12h dosing for diarrhea
  • Change to higher ratio formulation (14:1) if appropriate for indication
  • Add aggressive probiotic therapy before discontinuation

Frequently Asked Questions

Parent and clinician concerns about Augmentin